Aliases & Classifications for Hemarthrosis

MalaCards integrated aliases for Hemarthrosis:

Name: Hemarthrosis 12 52 42 14 69
Hemarthrosis Involving Pelvic Region and Thigh 12
Haemarthrosis of the Pelvic Region and Thigh 12
Hemarthrosis of the Pelvic Region and Thigh 12
Hemarthrosis Involving Shoulder Region 12
Hemarthrosis Involving Ankle and Foot 12
Hemarthrosis of the Ankle and/or Foot 12
Haemarthrosis of the Ankle and Foot 12
Hemarthrosis of the Shoulder Region 12
Hemarthrosis of the Ankle and Foot 12
Hemarthrosis of Ankle and/or Foot 12
Hemarthrosis Involving Lower Leg 12
Hemarthrosis Involving Upper Arm 12
Haemarthrosis of Shoulder Joint 12
Hemarthrosis of Shoulder Region 12
Hemarthrosis Involving Forearm 12
Hemarthrosis of the Lower Leg 12
Hemarthrosis of the Upper Arm 12
Hemarthrosis Involving Hand 12
Hemarthrosis of the Forearm 12
Hemarthrosis of Lower Leg 12
Hemarthrosis of Upper Arm 12
Hemarthrosis of Shoulder 12
Hemarthrosis of the Hand 12
Hemarthrosis of Forearm 12
Hemarthrosis of Hand 12

Classifications:



External Ids:

Disease Ontology 12 DOID:801
ICD10 33 M25.0
ICD9CM 35 719.1 719.10
MeSH 42 D006395
UMLS 69 C0018924

Summaries for Hemarthrosis

MalaCards based summary : Hemarthrosis, also known as hemarthrosis involving pelvic region and thigh, is related to factor x deficiency and factor v deficiency, and has symptoms including arthralgia, hemoptysis and metatarsalgia. An important gene associated with Hemarthrosis is F8 (Coagulation Factor VIII), and among its related pathways/superpathways are Metabolism of proteins and Response to elevated platelet cytosolic Ca2+. The drugs Bevacizumab and Hyaluronic acid have been mentioned in the context of this disorder. Affiliated tissues include bone, b cells and monocytes, and related phenotypes are cardiovascular system and homeostasis/metabolism

Wikipedia : 72 Hemarthrosis (or haemarthrosis) is a bleeding into joint spaces. It is a common feature of Hemophilia.... more...

Related Diseases for Hemarthrosis

Diseases related to Hemarthrosis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 97)
id Related Disease Score Top Affiliating Genes
1 factor x deficiency 31.3 F10 F7 F8 F9
2 factor v deficiency 31.0 F7 F8 F9
3 myocardial infarction 28.3 F10 F7 F8 VWF
4 afibrinogenemia, congenital 10.8
5 factor vii deficiency 10.8
6 intermediate anorectal malformation 10.4 F8 F9
7 acquired von willebrand syndrome 10.4 F8 F9
8 autonomic neuropathy 10.3 F8 F9
9 autosomal recessive disease 10.2 F8 F9
10 hemophilia 10.2
11 vaginal yolk sac tumor 10.2 F7 F9
12 social phobia 10.2 BGLAP F8
13 hydrarthrosis 10.1 F7 F9
14 papillary carcinoma 10.1 BGLAP SPP1
15 acquired pure red cell aplasia 10.0 F10 F8 F9
16 hypophosphatasia, adult 10.0 BGLAP SPP1
17 meckel's diverticulum 10.0 F10 F9
18 ubqln2-related amyotrophic lateral sclerosis/frontotemporal dementia 10.0 F8 VWF
19 uchl1-related parkinson disease susceptibility 10.0 F8 VWF
20 floppy infant syndrome 10.0 F8 VWF
21 glossopharyngeal nerve paralysis 10.0 F8 F9
22 ube2t-related fanconi anemia 10.0 F8 VWF
23 synovitis 10.0
24 von willibrand disease, type 3 10.0 F8 VWF
25 mitochondrial myopathy with lactic acidosis 10.0 BGLAP SPP1
26 femoral neuropathy 9.9 F8 VWF
27 renal adenoma 9.9 F8 VWF
28 physical disorder 9.9 BGLAP SPP1
29 scurvy 9.9
30 arthritis 9.9
31 von willebrand disease, type 1 9.9 F7 VWF
32 thumb stiff brachydactyly mental retardation 9.9 F8 VWF
33 intra-abdominal lymph node mast cell malignancy 9.9 F7 SPP1
34 van maldergem syndrome 2 9.8 F8 VWF
35 hemophilia a 9.8
36 acute myocardial infarction 9.8
37 thrombasthenia 9.8
38 aneurysm 9.8
39 immunodeficiency 21 9.7 F8 VWF
40 glanzmann thrombasthenia 9.7
41 osteoarthritis 9.7
42 pigmented villonodular synovitis 9.7
43 purpura 9.7
44 arthropathy 9.7
45 villonodular synovitis 9.7
46 acquired hemophilia 9.7
47 mild hemophilia b 9.7 F10 F8 VWF
48 agenesis of the dorsal pancreas 9.7 F10 F8 VWF
49 adams-oliver syndrome 5 9.7 SPP1 VWF
50 pregnancy loss, recurrent 2 9.7 F10 F8 VWF

Graphical network of the top 20 diseases related to Hemarthrosis:



Diseases related to Hemarthrosis

Symptoms & Phenotypes for Hemarthrosis

UMLS symptoms related to Hemarthrosis:


arthralgia, hemoptysis, metatarsalgia, joint swelling, other symptoms referable to joint, stiffness of joint, not elsewhere classified in icd10cm

MGI Mouse Phenotypes related to Hemarthrosis:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 9.35 F10 F7 F9 SPP1 VWF
2 homeostasis/metabolism MP:0005376 9.1 F10 F7 F8 F9 SPP1 VWF

Drugs & Therapeutics for Hemarthrosis

Drugs for Hemarthrosis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 46)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Bevacizumab Approved, Investigational Phase 4 216974-75-3
2
Hyaluronic acid Approved, Vet_approved Phase 4 9004-61-9 53477741 24759
3
Ropivacaine Approved Phase 4 84057-95-4 71273 175805
4
Triamcinolone Approved, Vet_approved Phase 4 124-94-7 31307
5
Benzocaine Approved Phase 4,Phase 3 1994-09-7, 94-09-7 2337
6 tannic acid Approved, Nutraceutical Phase 4,Phase 3
7 Angiogenesis Inhibitors Phase 4
8 Angiogenesis Modulating Agents Phase 4
9 Coagulants Phase 4,Phase 3,Phase 2
10 Factor VIII Phase 4,Phase 3,Phase 2
11 Adjuvants, Immunologic Phase 4
12 Hylan Phase 4
13 Protective Agents Phase 4
14 triamcinolone acetonide Phase 4
15 Triamcinolone diacetate Phase 4
16 Triamcinolone hexacetonide Phase 4
17 Viscosupplements Phase 4
18 Antibodies Phase 3
19 Immunoglobulin Fc Fragments Phase 3
20 Immunoglobulins Phase 3
21 Hemostatics Phase 3,Phase 2
22
Chlorhexidine Approved, Vet_approved 55-56-1 9552079 2713
23 Povidone-iodine Approved 25655-41-8
24
Thrombin Approved
25
Bupivacaine Approved, Investigational 2180-92-9, 38396-39-3 2474
26
Epinephrine Approved, Vet_approved 51-43-4 5816
27 Racepinephrine Approved
28 Chlorhexidine gluconate
29 Adrenergic Agents
30 Adrenergic Agonists
31 Adrenergic alpha-Agonists
32 Adrenergic beta-Agonists
33 Anesthetics
34 Anesthetics, Local
35 Anti-Asthmatic Agents
36 Autonomic Agents
37 Bronchodilator Agents
38 Central Nervous System Depressants
39 Epinephryl borate
40 Mydriatics
41 Narcotics
42 Neurotransmitter Agents
43 Peripheral Nervous System Agents
44 Respiratory System Agents
45 Vasoconstrictor Agents
46 Soy Bean Nutraceutical

Interventional clinical trials:

(show top 50) (show all 76)

id Name Status NCT ID Phase Drugs
1 Intra-articular Bevacizumab for Recurrent Hemarthroses at Target Joints With Chronic Hemophilic Synovitis Unknown status NCT02060305 Phase 4 Bevacizumab intra-articular injection
2 Subclinical Joint Bleeding in Irish Adults With Severe Haemophilia A on Personalised Prophylaxis Regimens Unknown status NCT02314325 Phase 4 ADVATE [Antihemophilic Factor (Recombinant)];ADVATE [Antihemophilic Factor (Recombinant)]
3 Trial of NovoSeven® in Haemophilia - Joint Bleeds Completed NCT00108797 Phase 4 eptacog alfa (activated);Feiba VH
4 High Dose of Activated Recombinant Human Factor VII for Treatment of Mild/Moderate Joint Bleeds in Haemophilia Patients With Inhibitors Completed NCT00571584 Phase 4 activated recombinant human factor VII
5 Viscosupplementation in Patients With Hemophilic Arthropathy Completed NCT01748201 Phase 4
6 Russian Kogenate Pediatric Study Completed NCT00632814 Phase 4 rFVIII-FS (Kogenate FS, BAY14-2222) 70 IU/kg, dosing once per week;rFVIII-FS (Kogenate FS, BAY14-2222), 70 IU/kg twice per week (30 IU/kg + 40 IU/kg);rFVIII-FS (Kogenate FS, BAY14-2222) 75 IU/kg, dosing three times per week (3 x 25 IU/kg)
7 BAY14-2222 Prophylaxis and Joint Function Improvement (Adults) Completed NCT00586521 Phase 4 Kogenate (BAY14-2222)
8 Impact of Conservative Treatment by Custom-made Orthoses in Patients With Haemophilic Ankle Arthropathy Completed NCT00638001 Phase 4
9 Canadian Hemophilia Prophylaxis Study Completed NCT01085344 Phase 4
10 Prophylaxis Versus on Demand Treatment for Children With Hemophilia A Completed NCT01810666 Phase 4
11 Efficacy and Cost Effectiveness of Pharmacokinetic Dosing in Haemophilia A Completed NCT02697370 Phase 4 Pharmacokinetic based dosage change
12 Joint Status in Subjects With Severe Hemophilia A in Relation to Different Treatment Regimens Completed NCT00927667 Phase 4
13 A Clinical Phenotype Based Individualized Prophylaxis in Chinese Hemophilia A Children Recruiting NCT02999308 Phase 4
14 Study Comparing On-Demand Treatment With Two Prophylaxis Regimens Of BeneFIX In Patients With Severe Hemophilia B Completed NCT00364182 Phase 3 Recombinant Coagulation Factor IX (BeneFIX);Recombinant Coagulation Factor IX (BeneFIX)
15 Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Recombinant Coagulation Factor VIII Fc Fusion Protein (rFVIIIFc) in Previously Treated Pediatric Subjects With Hemophilia A Completed NCT01458106 Phase 3 BIIB031 (rFVIIIFc);FVIII (PK subgroup only)
16 Study of Recombinant Coagulation Factor IX Fc Fusion Protein, BIIB029, in Previously Treated Pediatric Participants With Hemophilia B Completed NCT01440946 Phase 3 rFIXFc;FIX
17 Study to Evaluate the Safety, Pharmacokinetics and Efficacy of Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc) in Previously Treated Subjects With Severe Hemophilia A Completed NCT01181128 Phase 3 Factor VIII (rFVIIIFc);Advate®
18 Study to Determine the Safety and Efficacy of rFIXFc in Untreated Males With Severe Hemophilia B Recruiting NCT02234310 Phase 3
19 An Open Label Study to Determine the Safety and Efficacy of Replacement Factor VIII Protein (Known as rFVIIIFc) in Untreated Males With Severe Hemophilia A Recruiting NCT02234323 Phase 3
20 A Clinical Trial to Evaluate Prophylactic Emicizumab Versus no Prophylaxis in Hemophilia A Participants Without Inhibitors Active, not recruiting NCT02847637 Phase 3 Emicizumab
21 A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Prophylactic Emicizumab Versus no Prophylaxis in Hemophilia A Participants With Inhibitors Active, not recruiting NCT02622321 Phase 3 Emicizumab;rFVIIa
22 Long-Term Safety and Efficacy of rFVIIIFc in the Prevention and Treatment of Bleeding Episodes in Previously Treated Participants With Hemophilia A Active, not recruiting NCT01454739 Phase 3 rFVIIIFc
23 Long-Term Safety and Efficacy of rFIXFc in the Prevention and Treatment of Bleeding Episodes in Previously Treated Participants With Hemophilia B Active, not recruiting NCT01425723 Phase 3
24 BAX 855 PK-Guided Dosing Active, not recruiting NCT02585960 Phase 3
25 A Trial Investigating Safety and Efficacy of Treatment With BAY94-9027 in Severe Hemophilia A Active, not recruiting NCT01580293 Phase 2, Phase 3
26 A Study of Once-Weekly Emicizumab in Children and Adolescents With Hemophilia A and Factor VIII (FVIII) Inhibitors Enrolling by invitation NCT02795767 Phase 3 Emicizumab
27 Efficacy, Safety, and Pharmacokinetic Study of Prophylactic Emicizumab Versus No Prophylaxis in Hemophilia A Participants Not yet recruiting NCT03315455 Phase 3 Emicizumab
28 Early Prophylaxis Immunologic Challenge (EPIC) Study Terminated NCT01376700 Phase 3
29 rFVIIa Prophylaxis in Children With Hemophilia A and Inhibitors Unknown status NCT01105546 Phase 2 recombinant activated factor VII;recombinant activated factor VII
30 Haemophilia Patients With Inhibitors Being Treated for Acute Joint Bleeds Completed NCT00486278 Phase 2 eptacog alfa (activated);vatreptacog alfa (activated);vatreptacog alfa (activated);vatreptacog alfa (activated);vatreptacog alfa (activated);vatreptacog alfa (activated)
31 Study of Recombinant Porcine Factor VIII (FVIII) in Hemophilia and Inhibitors to FVIII Completed NCT00245245 Phase 2 recombinant porcine coagulation factor VIII (OBI-1)
32 A Proof-of-Concept Study of AC-201 Controlled-Release Tablet (CR Tablet) in Patients With Hemophilic Arthropathy Recruiting NCT02994147 Phase 2 Placebo;AC-201CR
33 BAY79-4980 Compared to rFVIII-FS in Previously Treated Patients With Severe Hemophilia A Terminated NCT00623727 Phase 2
34 Individualized Prophylaxis for Severe Hemophilia A Children Unknown status NCT02116855
35 The Effect of Functional Activities and Balance Ability With Taping in Subjects of Hemophilia Unknown status NCT02389205
36 Biomechanical Determinants and Patterns Associated to the Pathophysiological Cascade of Ankle Arthropathy in Children With Haemophilia: Non-invasive In-vivo Measurement of Foot Joints in Children With Haemophilia During Gait. Unknown status NCT02229331
37 Musculoskeletal Function in Hemophilia Unknown status NCT00324493
38 Assessment of Proprioceptive and Functional Characteristics in Patients With Hemophilia Unknown status NCT02165592
39 Observational Study Describing the Usual Clinical Practice Use of NovoSeven® in the Home Treatment of Joint Bleeds in Patients With Haemophilia A or B and Inhibitors Completed NCT01234545 activated recombinant human factor VII
40 The FEIBA NovoSeven Comparative Study Completed NCT00166309 FEIBA and NovoSeven
41 Efficacy of Peroperative Suction Drain Usage in Arthroscopic Knee Surgery Completed NCT02752581
42 Physiotherapy in the Haemophilic Arthropathy of the Elbow. Completed NCT02198040
43 Manual Therapy in Haemophilic Arthropathy of the Knee Completed NCT02198014
44 The Von Willebrand Disease (VWD) International Prophylaxis Study Completed NCT00557908 VWF/FVIII products
45 Multidisciplinary Evaluation of Patients With Hemophilia Completed NCT02198430
46 Gait Evaluation in Haemophiliac Patients Completed NCT00824798
47 Educational Physiotherapy in Haemophilia Completed NCT02825706
48 Bilateral Deficit Phenomenon in Patients With Haemophilic Arthropathy Completed NCT02165462
49 Platelet-Rich Plasma Intra-Articular Injection in Treating Hemophilic Arthropathy Completed NCT02601170 Hyaluronic Acid Viscosupplementation
50 Prophylaxis Versus On-demand Therapy Through Economic Report Completed NCT01159587 Recombinant Factor VIII (Kogenate FS, BAY14-2222);Recombinant Factor VIII (Kogenate FS, BAY14-2222)

Search NIH Clinical Center for Hemarthrosis

Cochrane evidence based reviews: hemarthrosis

Genetic Tests for Hemarthrosis

Anatomical Context for Hemarthrosis

MalaCards organs/tissues related to Hemarthrosis:

39
Bone, B Cells, Monocytes, Myeloid, Skeletal Muscle

Publications for Hemarthrosis

Articles related to Hemarthrosis:

(show top 50) (show all 229)
id Title Authors Year
1
Endovascular Management of Recurrent Spontaneous Hemarthrosis After Arthroplasty. ( 27882429 )
2017
2
Hemarthrosis subtalar, a rare diagnosis. ( 28409144 )
2017
3
Spontaneous elbow hemarthrosis identified by point-of-care ultrasound. ( 28435904 )
2017
4
Hemarthrosis and scurvy. ( 28433625 )
2017
5
Recurrent Hemarthrosis due to Iatrogenic AVF Treated With Onyx Embolization. ( 28446073 )
2017
6
Spontaneous Recurrent Hemarthrosis of the Knee: A Report of Two Cases with a Source of Bleeding Detected during Arthroscopic Surgery of the Knee Joint. ( 27703824 )
2016
7
Reducing Intra-articular Hemarthrosis After Arthroscopic ACL Reconstruction: Letter to the Editor. ( 26929178 )
2016
8
Geniculate Artery Embolization for Management of Recurrent Hemarthrosis: A Single-Center Experience. ( 27338503 )
2016
9
Epidemiology of intra- and peri-articular structural injuries in traumatic knee joint hemarthrosis - data from 1145 consecutive knees with subacute MRI. ( 27374877 )
2016
10
Effects of hemarthrosis on cartilage and synovium in rabbits. ( 26936196 )
2016
11
Spontaneous Hemarthrosis of the Knee - Late Complication of Flexible Femur Nailing: A Case Report. ( 28180118 )
2016
12
Technically Successful Geniculate Artery Embolization Does Not Equate Clinical Success for Treatment of Recurrent Knee Hemarthrosis after Knee Surgery. ( 26806692 )
2016
13
Acute Hemarthrosis of the Knee Caused by Arteriovenous Malformation. ( 27231206 )
2016
14
Reducing Intra-articular Hemarthrosis After Arthroscopic ACL Reconstruction: Response. ( 26929179 )
2016
15
Abnormal joint and bone wound healing in hemophilia mice is improved by extending factor IX activity after hemarthrosis. ( 28039188 )
2016
16
Geniculate artery embolization for recurrent postarthroplasty hemarthrosis of the knee. ( 27398122 )
2015
17
Joint Aspiration for Acute Hemarthrosis in Children Receiving Factor VIII Prophylaxis for Severe Hemophilia: 11-year Safety Data. ( 25729030 )
2015
18
Recurrent Hemarthrosis Following Knee Arthroplasty Treated with Arterial Embolization. ( 26092252 )
2015
19
Reducing Intra-articular Hemarthrosis After Arthroscopic Anterior Cruciate Ligament Reconstruction by the Administration of Intravenous Tranexamic Acid: A Prospective, Randomized Controlled Trial. ( 26337246 )
2015
20
LASER versus electromagnetic field in treatment of hemarthrosis in children with hemophilia. ( 26306883 )
2015
21
Occult Intra-articular Knee Injuries in Children With Hemarthrosis. ( 24753236 )
2014
22
Anticoagulant-induced hemarthrosis presenting as anterior shoulder dislocation. ( 25043625 )
2014
23
Spontaneous hemarthrosis in combined Glanzmann thrombasthenia and type 2N von Willebrand disease. ( 24418945 )
2014
24
Spontaneous hemarthrosis following fibrinolytic therapy for acute myocardial infarction: a case report and literature review. ( 25417208 )
2014
25
Selective arterial embolization with gelatin particles for refractory knee hemarthrosis. ( 23846552 )
2013
26
Antiplasmin, but not amiloride, prevents synovitis and cartilage damage following hemarthrosis in hemophilic mice. ( 24283895 )
2013
27
Recurrent hemarthrosis : an unusual cause. ( 23680622 )
2013
28
A case of bilateral hemarthrosis due to pseudoaneurysms in a patient on anticoagulation therapy. ( 23669803 )
2013
29
Hemarthrosis in hemophilic mice results in alterations in M1-M2 monocyte/macrophage polarization. ( 24252538 )
2013
30
A case of selective arterial embolization for recurrent hemarthrosis after total knee arthroplasty. ( 22237971 )
2013
31
Hemophilic chronic synovitis: therapy of hemarthrosis using endovascular embolization of knee and elbow arteries. ( 23150120 )
2013
32
Recurrent hemarthrosis after total knee arthroplasty caused by the impingement of a remnant lateral meniscus: A case report. ( 24231622 )
2013
33
Geniculate artery embolization in the management of spontaneous recurrent hemarthrosis of the knee: case series. ( 23433418 )
2013
34
Knee hemarthrosis after arthroscopic surgery in an athlete with low factor XIII activity. ( 23031577 )
2012
35
Hemarthrosis in a patient on warfarin receiving ceftaroline: a case report and brief review of cephalosporin interactions with warfarin. ( 22764328 )
2012
36
MRI findings in adolescent patients with acute traumatic knee hemarthrosis. ( 23147616 )
2012
37
Spontaneous recurrent hemarthrosis of the knee joint in the elderly: a report of two cases. ( 21607723 )
2012
38
Cartilage and bone markers and inflammatory cytokines are increased in synovial fluid in the acute phase of knee injury (hemarthrosis)--a cross-sectional analysis. ( 22874525 )
2012
39
Intra-articular nodular fasciitis of the knee: a rare cause of recurrent hemarthrosis. ( 21431289 )
2012
40
Transarterial embolization for the management of hemarthrosis of the knee. ( 22154590 )
2012
41
Magnetic resonance angiography in the management of recurrent hemarthrosis after total knee arthroplasty. ( 21397454 )
2011
42
Does the source of hemarthrosis influence posttraumatic joint contracture and biomechanical properties of the joint? ( 21420211 )
2011
43
Recurrent hemarthrosis in a boy with synovial hemangioma: a case report. ( 21088622 )
2011
44
Trauma resulting in hemarthrosis and long medial collateral ligament desmitis of the tarsocrural joint in a horse. ( 22043073 )
2011
45
Recurrent hemarthrosis after unicompartmental knee arthroplasty. ( 21902161 )
2011
46
A rare case of meniscal hematoma with hemarthrosis of the knee: a case report. ( 21938355 )
2011
47
Late recurrent hemarthrosis following knee arthroplasty associated with epithelioid angiosarcoma of bone. ( 19945286 )
2010
48
Recurrent hemarthrosis in a hemophilic patient after revision total knee arthroplasty. ( 20954656 )
2010
49
Glanzmann thrombasthenia detected because of knee hemarthrosis: a case report. ( 20736850 )
2010
50
Spontaneous recurrent hemarthrosis of the knee joint in elderly patients with osteoarthritis: an infrequent presentation of synovial lipoma arborescens. ( 20526580 )
2010

Variations for Hemarthrosis

Expression for Hemarthrosis

Search GEO for disease gene expression data for Hemarthrosis.

Pathways for Hemarthrosis

Pathways related to Hemarthrosis according to GeneCards Suite gene sharing:

(show all 11)
id Super pathways Score Top Affiliating Genes
1
Show member pathways
13.3 BGLAP F10 F7 F8 F9
2
Show member pathways
12.8 F10 F7 F8 F9 VWF
3
Show member pathways
12.39 F10 F7 F8 F9
4
Show member pathways
11.76 F10 F7 F8 F9 VWF
5
Show member pathways
11.59 BGLAP F10 F7 F9
6 11.5 F10 F7 F8 F9 VWF
7 11.48 BGLAP SPP1
8 11.13 BGLAP SPP1
9 11.09 BGLAP SPP1
10 11 BGLAP SPP1
11 10.1 BGLAP F10 F7 F9

GO Terms for Hemarthrosis

Cellular components related to Hemarthrosis according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 extracellular space GO:0005615 9.72 BGLAP F7 F8 F9 SPP1
2 extracellular region GO:0005576 9.7 BGLAP F10 F7 F8 F9 SPP1
3 vesicle GO:0031982 9.43 BGLAP F7 SPP1
4 platelet alpha granule lumen GO:0031093 9.37 F8 VWF
5 Golgi lumen GO:0005796 9.26 BGLAP F10 F7 F9
6 endoplasmic reticulum lumen GO:0005788 9.1 BGLAP F10 F7 F8 F9 SPP1

Biological processes related to Hemarthrosis according to GeneCards Suite gene sharing:

(show all 13)
id Name GO ID Score Top Affiliating Genes
1 blood coagulation GO:0007596 9.8 F10 F7 F8 F9 VWF
2 ER to Golgi vesicle-mediated transport GO:0006888 9.77 BGLAP F10 F7 F8 F9
3 signal peptide processing GO:0006465 9.56 BGLAP F10 F7 F9
4 positive regulation of protein kinase B signaling GO:0051897 9.52 F10 F7
5 response to estrogen GO:0043627 9.51 BGLAP F7
6 blood coagulation, extrinsic pathway GO:0007598 9.5 F10 F7 F9
7 response to nutrient levels GO:0031667 9.49 BGLAP F7
8 biomineral tissue development GO:0031214 9.48 BGLAP SPP1
9 response to vitamin D GO:0033280 9.46 BGLAP SPP1
10 blood coagulation, intrinsic pathway GO:0007597 9.46 F10 F8 F9 VWF
11 response to vitamin K GO:0032571 9.43 BGLAP F7
12 peptidyl-glutamic acid carboxylation GO:0017187 9.26 BGLAP F10 F7 F9
13 hemostasis GO:0007599 9.02 F10 F7 F8 F9 VWF

Molecular functions related to Hemarthrosis according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 serine-type endopeptidase activity GO:0004252 9.33 F10 F7 F9
2 endopeptidase activity GO:0004175 9.26 F7 F9
3 calcium ion binding GO:0005509 9.26 BGLAP F10 F7 F9
4 serine-type peptidase activity GO:0008236 8.8 F10 F7 F9

Sources for Hemarthrosis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....